Skip to main content

Emerald Health Therapeutics Inc (EMH-X) Quote

Unchecking box will stop auto data updates
TSX Venture Real-Time Last Sale CAD
Today's Change
Price Quote as of

Today's Trading

Day Low 1.980
Day High 2.040
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Emerald Health Therapeutics Inc is a vertically integrated Canadian licensed producer of cannabis, focused on developing proprietary, cannabis products for medical and adult-use customers. The company's Pure Sunfarms joint venture has two 1.1 M sf greenhouses. The Verdelite operation in Quebec is an approx. 88,000 sf indoor facility licensed for cultivation and production. It has contracted around 1000 acres of hemp in 2019 to 2022. Through strategic partnerships, the company has secured industrial extraction, softgel encapsulation and formulation technology for innovative product development.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Infused Drinks Offer Users a New Way to Enjoy Cannabis
- PR Newswire - Tue Aug 13, 8:00AM CDT
PR Newswire - CMTX
Tue Aug 13, 8:00AM CDT
The increasing acceptance of cannabidiol or CBD has pushed the overall cannabis industry into mainstream markets. Previously, CBD was listed as a Schedule 1 drug, meaning it was among one of the most heavily regulated substances in the world. However, through extensive research, scientists have concluded that CBD can actually have medical benefits. Researchers have praised the compound for its therapeutic benefits as it can be used as an alternative to traditional medicines. Moreover, clinical trials have also concluded that CBD does not cause psychoactive effects, unlike its THC or tetrahydrocannabinol counterpart. The positive outcome from CBD trials even led the U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration to delist the compound from the Schedule 1 list. Additionally, the U.S. federal government signed the Farm Bill in 2018, which caused a widespread emergence of CBD-based products in stores throughout the nation. In particular, products such as tinctures, extracts, topicals, and beverages have been well received and are popular among consumers. Specifically, infused beverages became widely popular because they introduced a new method to consume cannabis aside from smoking or vaping. With the overall decline in smoking, as well as the increase in consumers seeking functional beverages, the CBD beverage industry has positioned itself to become a thriving market. Notably, the concept of self-care is causing the CBD beverage market to witness growth because consumers can easily purchase products at local stores or even on ecommerce platforms. Moreover, consumers are looking for a more natural product rather than the current commercialized health and wellness products that are packed with chemicals. However, despite the growing popularity of CBD beverages, there are still a multitude of people that are hesitant on trying them because of the legality matter revolving around cannabis. However, as cannabis continues to push into mainstream markets, the stigma imposed on the plant will eventually diminish. According to data compiled by Ameri Research, the global legal marijuana market was valued at USD 14.3 Billion in 2016. By 2024, legal marijuana global sales are projected to reach USD 63.5 Billion while exhibiting a CAGR of 21.1% from 2017 to 2024. BevCanna Enterprises Inc. (OTC: BVNNF) (CSE: BEV), Aphria Inc. (NYSE: APHA) (TSX: APHA), Valens GroWorks Corp. (OTC: VGWCF) (TSX-V: VGW), The Alkaline Water Company Inc. (NASDAQ: WTER) (TSX-V: WTER), Emerald Health Therapeutics Inc. (OTC: EMHTF) (TSX-V: EMH).
Emerald Health Therapeutics' Pure Sunfarms JV Reaches Q2 Sales of $32 Million, 78% EBITDA Margin, $0.65/Gram All-in Production Cost, and Third Consecutive Quarter of Profitability
- GlobeNewswire - Mon Aug 12, 11:19PM CDT
GlobeNewswire - CMTX
Mon Aug 12, 11:19PM CDT
Emerald Health Therapeutics, Inc. ("Emerald") (TSXV: EMH; OTCQX: EMHTF) has provided preliminary, unaudited financial results for the second quarter of 2019 for its BC-based 50%-owned joint venture, Pure Sunfarms (PSF). The Company will report its complete financial results for the second quarter ended June 30, 2019, after market close on Wednesday, August 28, 2019, and host its second quarter 2019 financial results conference call on Thursday, August 29, 2019 at 10:30 a.m. ET.
Emerald Health Therapeutics Outlines Production and Processing Advancements
- GlobeNewswire - Tue Aug 6, 6:01AM CDT
GlobeNewswire - CMTX
Tue Aug 6, 6:01AM CDT
Emerald Health Therapeutics, Inc. ("Emerald") (TSXV: EMH; OTCQX: EMHTF) today provided updates on its various cultivation and processing initiatives.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 1.830 +11.48% increase
on 08/09/19
Period Open:2.280
Price movement based on the high, low and last over the given period.
2.650 -23.02% decrease
on 08/06/19
-0.240 (-10.53%) decrease
since 07/16/19
3-Month 1.830 +11.48% increase
on 08/09/19
Period Open:3.700
Price movement based on the high, low and last over the given period.
3.850 -47.01% decrease
on 05/28/19
-1.660 (-44.86%) decrease
since 05/16/19
52-Week 1.830 +11.48% increase
on 08/09/19
Period Open:2.790
Price movement based on the high, low and last over the given period.
5.920 -65.54% decrease
on 09/11/18
-0.750 (-26.88%) decrease
since 08/16/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).